251 related articles for article (PubMed ID: 12813457)
1. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.
Ehrhardt H; Fulda S; Schmid I; Hiscott J; Debatin KM; Jeremias I
Oncogene; 2003 Jun; 22(25):3842-52. PubMed ID: 12813457
[TBL] [Abstract][Full Text] [Related]
2. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
4. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
5. The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells.
Franco AV; Zhang XD; Van Berkel E; Sanders JE; Zhang XY; Thomas WD; Nguyen T; Hersey P
J Immunol; 2001 May; 166(9):5337-45. PubMed ID: 11313369
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
Wuchter C; Krappmann D; Cai Z; Ruppert V; Scheidereit C; Dörken B; Ludwig WD; Karawajew L
Leukemia; 2001 Jun; 15(6):921-8. PubMed ID: 11417478
[TBL] [Abstract][Full Text] [Related]
7. Caspase cleavage product lacking amino-terminus of IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis.
Kim KW; Kim BJ; Chung CW; Jo DG; Kim IK; Song YH; Kwon YK; Woo HN; Jung YK
J Cell Biochem; 2002; 85(2):334-45. PubMed ID: 11948689
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death.
Thomas RP; Farrow BJ; Kim S; May MJ; Hellmich MR; Evers BM
Surgery; 2002 Aug; 132(2):127-34. PubMed ID: 12219002
[TBL] [Abstract][Full Text] [Related]
9. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation.
Leverkus M; Sprick MR; Wachter T; Mengling T; Baumann B; Serfling E; Bröcker EB; Goebeler M; Neumann M; Walczak H
Mol Cell Biol; 2003 Feb; 23(3):777-90. PubMed ID: 12529384
[TBL] [Abstract][Full Text] [Related]
13. Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.
An J; Sun YP; Adams J; Fisher M; Belldegrun A; Rettig MB
Clin Cancer Res; 2003 Oct; 9(12):4537-45. PubMed ID: 14555528
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells.
Karacay B; Sanlioglu S; Griffith TS; Sandler A; Bonthius DJ
Cancer Gene Ther; 2004 Oct; 11(10):681-90. PubMed ID: 15332116
[TBL] [Abstract][Full Text] [Related]
15. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
16. Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.
Chawla-Sarkar M; Bauer JA; Lupica JA; Morrison BH; Tang Z; Oates RK; Almasan A; DiDonato JA; Borden EC; Lindner DJ
J Biol Chem; 2003 Oct; 278(41):39461-9. PubMed ID: 12881518
[TBL] [Abstract][Full Text] [Related]
17. Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors.
Zheng B; Georgakis GV; Li Y; Bharti A; McConkey D; Aggarwal BB; Younes A
Clin Cancer Res; 2004 May; 10(9):3207-15. PubMed ID: 15131062
[TBL] [Abstract][Full Text] [Related]
18. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).
Ravi R; Bedi A
Cancer Res; 2002 Mar; 62(6):1583-7. PubMed ID: 11912124
[TBL] [Abstract][Full Text] [Related]
19. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases.
Harper N; Farrow SN; Kaptein A; Cohen GM; MacFarlane M
J Biol Chem; 2001 Sep; 276(37):34743-52. PubMed ID: 11461927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]